The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
Open accessAbstract
Receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) is expressed during embryogenesis and by certain leukemias, but not by normal adult tissues. Here we show that the neoplastic cells of many human breast cancers express the ROR1 protein and high-level expression of ROR1 in breast adenocarcinoma was associated with aggressive disease. Silencing expression of ROR1 in human breast cancer cell lines found to express this protein impaired their growth in vitro and also in immune-deficient mice. We found that ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB), which was associated with enhanced tumor-cell growth. Wnt5a, a ligand of ROR1, could induce ROR1-dependent signaling and enhance cell growth. This study demonstrates that ROR1 is expressed in human breast cancers and has biological and clinical significance, indicating that it may be a potential target for breast cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587 · cited 1×
“serine-133 (Ser-133), which is a feature of activated CREB [25].”
BackgroundPrognostic markers in triple‐negative breast cancer
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007) · Cancer · doi:10.1002/cncr.22381 · Cited by 1,283
Zhang, X., Odom, D. T., Koo, S.-H., Conkright, M. D., Canettieri, G., Best, J., Chen, H., Jenner, R., Herbolsheimer, E., Jacobsen, E., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501076102 · Cited by 992
CREB Is a Regulatory Target for the Protein Kinase Akt/PKB
Du, K., & Montminy, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32377 · Cited by 952
Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N., Mejia, J. A., Booser, D., Theriault, R. L., Buzdar, A. U., Dempsey, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6861 · Cited by 721
MacKeigan, J. P., Murphy, L. O., & Blenis, J. (2005) · Nature Cell Biology · doi:10.1038/ncb1258 · Cited by 561
In vivo imaging of light-emitting probes
Rice, B. W., Cable, M. D., & Nelson, M. B. (2001) · Journal of Biomedical Optics · doi:10.1117/1.1413210 · Cited by 493
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia
Lu, D., Zhao, Y., Tawatao, R., Cottam, H. B., Sen, M., Leoni, L. M., Kipps, T. J., Corr, M., & Carson, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308648100 · Cited by 420
Self-citationWnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trümper, L., & Binder, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509703103 · Cited by 363
Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J. E., Widhopf, G. F., Rassenti, L. Z., Cantwell, M. J., Prussak, C. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712148105 · Cited by 312
Self-citationRecessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2
Afzal, A. R., Rajab, A., Fenske, C. D., Oldridge, M., Elanko, N., Ternes-Pereira, E., Tüysüz, B., Murday, V. A., Patton, M. A., Wilkie, A. O. M., et al. (2000) · Nature Genetics · doi:10.1038/78107 · Cited by 305
Sakamoto, K. M., & Frank, D. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1137 · Cited by 279
A novel family of cell surface receptors with tyrosine kinase-like domain.
Masiakowski, P., & Carroll, R. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35733-8 · Cited by 272
DeChiara, T. M., Kimble, R. B., Poueymirou, W. T., Rojas, J., Masiakowski, P., Valenzuela, D. M., & Yancopoulos, G. D. (2000) · Nature Genetics · doi:10.1038/73488 · Cited by 251
Baskar, S., Kwong, K. Y., Hofer, T., Levy, J. M., Kennedy, M. G., Lee, E., Staudt, L. M., Wilson, W. H., Wiestner, A., & Rader, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1823 · Cited by 238
Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B
Oldridge, M., M Fortuna, A., Maringa, M., Propping, P., Mansour, S., Pollitt, C., DeChiara, T. M., Kimble, R. B., Valenzuela, D. M., Yancopoulos, G. D., et al. (2000) · Nature Genetics · doi:10.1038/73495 · Cited by 231
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation
Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh, K., Tamura, S., Ueda, T., Hatta, T., Otani, H., et al. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00300.x · Cited by 222
Aberrant expression of the growth factor Wnt-5A in human malignancy.
Iozzo, R. V., Eichstetter, I., & Danielson, K. G. (1995) · PubMed · Cited by 187
DaneshManesh, A. H., Mikaelsson, E., Jeddi‐Tehrani, M., Bayat, A. A., Ghods, R., Ostadkarampour, M., Akhondi, M., Lagercrantz, S., Larsson, C., Österborg, A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23587 · Cited by 177
Targeting CREB for Cancer Therapy: Friend or Foe
Xiao, X., Li, B. X., Mitton, B., Ikeda, A., & Sakamoto, K. M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791208535 · Cited by 160
Oishi, I., Takeuchi, S., Hashimoto, R., Nagabukuro, A., Ueda, T., Liu, Z., Hatta, T., Akira, S., Matsuda, Y., Yamamura, H., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00234.x · Cited by 153
Nomi, M., Oishi, I., Kani, S., Suzuki, H., Matsuda, T., Yoda, A., Kitamura, M., Itoh, K., Takeuchi, S., Takeda, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8329-8335.2001 · Cited by 153
Wnt5a cloning, expression, and up-regulation in human primary breast cancers.
LeJeune, S., Huguet, E., Hamby, A. M., Poulsom, R., & Harris, A. L. (1995) · PubMed · Cited by 152
A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury
Sun, C.-X., Young, H. W. J., Molina, J. G., Volmer, J. B., Schnermann, J. B., & Blackburn, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22656 · Cited by 140
Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
Gentile, A., Lazzari, L., Benvenuti, S., Trusolino, L., & Comoglio, P. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2662 · Cited by 138
Wilson, C., Goberdhan, D. C. I., & Steller, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7109 · Cited by 135
The Ror receptor tyrosine kinase family
Forrester, W. C. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8407-9 · Cited by 122
CREB is a critical regulator of normal hematopoiesis and leukemogenesis
Cheng, J. C., Kinjo, K., Judelson, D. R., Chang, J. C.-C., Wu, W. S., Schmid, I., Shankar, D. B., Kasahara, N., Stripecke, R., Bhatia, R., et al. (2007) · Blood · doi:10.1182/blood-2007-04-083600 · Cited by 121
Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis
Chhabra, A., Fernando, H. S., Watkins, G., Mansel, R. E., & Jiang, W. G. (2007) · Oncology Reports · doi:10.3892/or.18.4.953 · Cited by 113
The Receptor Tyrosine Kinase Ror2 Associates with and Is Activated by Casein Kinase Iϵ
Kani, S., Oishi, I., Yamamoto, H., Yoda, A., Suzuki, H., Nomachi, A., Iozumi, K., Nishita, M., Kikuchi, A., Takumi, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409039200 · Cited by 112
Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
Yang, W. S., & Stockwell, B. R. (2008) · Genome biology · doi:10.1186/gb-2008-9-6-r92 · Cited by 104
RNAi screen for rapid therapeutic target identification in leukemia patients
Tyner, J. W., Deininger, M. W., Loriaux, M., Chang, B. H., Gotlib, J. R., Willis, S. G., Erickson, H. S., Kovacsovics, T. J., O’Hare, T., Heinrich, M. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903233106 · Cited by 99
Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
Choudhury, A., Derkow, K., Daneshmanesh, A. H., Mikaelsson, E., Kiaii, S., Kokhaei, P., Österborg, A., & Mellstedt, H. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08362.x · Cited by 92
Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein
Aggarwal, S., Kim, S. W., Ryu, S.-H., Chung, W.-C., & Koo, J. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-06-0249 · Cited by 92
Shabani, M., Asgarian‐Omran, H., Jeddi‐Tehrani, M., Vossough, P., Faranoush, M., Sharifian, R. A., Toughe, G. R., Kordmahin, M., Khoshnoodi, J., Roohi, A., et al. (2007) · Tumor Biology · doi:10.1159/000121405 · Cited by 51
Human Adaptive Immune System Rag2−/−γc−/− Mice
Chicha, L., Tussiwand, R., Traggiai, E., Mazzucchelli, L., Bronz, L., Piffaretti, J.-C., Lanzavecchia, A., & Manz, M. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.029 · Cited by 44
Linnerth-Petrik, N. M., Greenaway, J. B., Petrik, J., & Moorehead, R. A. (2008) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01177.x · Cited by 42
Ba, S. (1979) · PubMed · Cited by 8
Cited by
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xu, X., Zhang, M., Xu, F., & Jiang, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01276-5 · Cited by 588
Hudecek, M., Lupo-Stanghellini, M.-T., Kosasih, P. L., Sommermeyer, D., Jensen, M. C., Rader, C., & Riddell, S. R. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0330 · Cited by 544
Katoh, M. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4129 · Cited by 465
A ROR1–HER3–lncRNA signalling axis modulates the Hippo–YAP pathway to regulate bone metastasis
Li, C., Wang, S., Xing, Z., Lin, A., Liang, K., Song, J., Hu, Q., Yao, J., Chen, Z., Park, P. K., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3464 · Cited by 316
Self-citation
Metadata
- Authors
- Zhang, S., Chen, L., Cui, B., Chuang, H.-Y., Yu, J., Wang-Rodriguez, J., Tang, L., Chen, G., Basak, G. W., & Kipps, T. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-05
- Volume
- 7
- Issue
- 3
- Pages
- e31127
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1975711182
- Cited by
- 260
- References
- 42
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.